Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
DSC Purity Determination of Drug Substances Drug substances have to be checked for purity as they are mostly used at purity levels greater than 99.9%. The check is frequently performed by HPLC although a further method is often necessary where High Performance Liquid Chromatography (HPLC) analysis is not suitable. In such cases, the DSC 1 differential scanning calorimeter offers a reliable alternative. Purity determination is performed by analyzing the melting behavior of the substance in question. The method is based on van’t Hoff’s law of melting point depression. The drug substance is slowly heated and the DSC curve recorded. Peak shape analysis of the main melting peak is performed semi-automatically with STARe software. The evaluation of typical measurements is shown in Figure 1. Pure p-hydroxybenzoic acid and various esters were heated to melting point in hermetically sealed aluminum crucibles. Figure 1. below shows the detailed evaluation of the p-hydroxybenzoic acid. The curve was evaluated between 10 and 50% peak height using the ‘line’ baseline type. The purity of substances was also determined by HPLC. The results are summarized in Table 1. The substances investigated show a high degree of purity. The results from DSC and from HPLC can be looked upon as being identical within the limits of measurement accuracy. e STAR } www.mt.com/dsc Figure 1: Purity determination of 4-hydroxybenzoic acid and its butyl (2), propyl (3), ethyl (4) and methyl (5) esters. Substance 1 Melting point Enthalpy of fusion 214.3 244 100 Purity by DSC Purity by HPLC 99.90 2 125.8 173 3 115.8 160 4 96.4 152 5 69.1 160 Unit °C J/g 99.89 99.88 99.65 99.76 mol% 99.96 99.94 99.87 99.98 wt% Table 1: Purity of (1) 4-hydroxybenzoic acid, and the (2) butyl-, (3) propyl-, (4) ethyl- and (5) methyl-4-hydroxybenzoates. METTLER TOLEDO PharmaNews 7